TipRanks
Go Ultimate55% OFF

SAB Biotherapeutics (SABS) Cash flow

SAB Biotherapeutics Cash Flow

SABS's free cash flow for Q2 2026 was $-26.68M. For the 2026 fiscal year, SABS's free cash flow was decreased by $-2.57M and operating cash flow was $-24.11M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Mar 25Dec 23Mar 23Dec 21
$ -44.78M$ -34.29M$ -25.12M$ -23.46M$ 1.99M
$ -121.71M$ -11.96M$ -152.70K$ -2.09M$ -10.94M
$ 168.30M$ -1.17M$ 66.77M$ 1.05M$ 35.89M
$ 10.50M$ 8.90M$ 56.57M$ 15.05M$ 39.55M
$ -45.71M$ -34.63M$ -25.32M$ -25.63M$ -8.96M

Currency in USD

SAB Biotherapeutics Cash Flow

-200M-100M0100M200M2019202020212022202320242025OperatingInvestingFinancing